August 13th 2025
Hidden signs of systemic disease, including heart attacks, may first reveal themselves through visual symptoms or subtle patient cues in the exam chair.
Incidence rate of conjunctival melanoma in Australia increased over 3 decades
March 30th 2024While the change is mostly a result of improved recognition of in situ cases, authors wanted to identify any changes in the incidence and mortality of conjunctival melanoma in Australia from 1982 to 2014.
Read More
During a presentation at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Yuichi Hori, MD, PhD, and colleagues found that taping the top border of a surgical mask to a clinicians’ skin reduces the potential for ocular surface damage resulting from expirations of air reaching the ocular surface during the COVID-19 pandemic.
Read More
Study examines high performance microscopy for non-invasive conjunctival goblet cell examination
April 8th 2022A team of investigators from Pohang University of Science and Technology has found that conjunctival goblet cell examination is important for the precise diagnosis and effective treatment of ocular surface diseases; however, CGC examination has not been possible until now due to lack of non-invasive devices.
Read More
University of Arizona engineer leads $1 million project to fight vision loss
March 14th 2022Dongkyun Lang, a biomedical engineering and optical sciences professor, is developing a way to diagnose and treat corneal ulcers that is eight times cheaper and 20 times faster than today's gold standard.
Read More
The latest on MGD reimbursements: LipiFlow and TearCare are still out-of-pocket procedures
February 25th 2022Cynthia Matossian, MD, FACS, ABES, points out that there has been confusing news lately about what is (and is not) covered by Medicare when it comes to in-office treatments for meibomian gland dysfunction.
Read More